Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises Conexa Health on $5.1 Million Investment from Vivo Ventures

  • 12/26/23
  • Client Highlights
  • Digital Health
  • Life Sciences

On December 13, 2023, Vivo Ventures announced a $5.1 million investment in Conexa Health, Latin America's largest digital health platform. In this investment, Vivo Ventures had the support of several renowned growth funds, such as Kamaroopin, Goldman Sachs, General Atlantic, and Igah, Ventures. Conexa Health has a controlling stake in Brazil-based Conexa Saude Servicos Medicos, which supplies a range of digital health-related products. The brand provides a telehealth platform connecting professionals to patients, internal systems for medical facilities, and a corporate offering targeted at general enterprise.

Wilson Sonsini Goodrich & Rosati represented Conexa Health in the transaction. The Wilson Sonsini team was led by Cesar Fischer.

For more information, please see the press release and additional coverage by Mobile World Live.